ClinicalTrials.Veeva

Menu

Real Word Study on Myopia Control With Repeated Red Light Therapy for Ages of 3~6 Years Old (RMC)

B

Beijing Airdoc Technology

Status

Enrolling

Conditions

Myopia
Amblyopia

Treatments

Device: repeated ultra low lever red light

Study type

Interventional

Funder types

Industry

Identifiers

NCT05811598
Beijing Airdoc Technology Co.,

Details and patient eligibility

About

Repeated Red Light Therapy had been used as an amblyopia therapy for children as well as the myopia control in primary schools. However, ultra low lever of red light therapy with irradiance of 0.37mW and 0.60mW effectiveness and safety for 3~ 6 year-old myopia treatment or slow myopia progression are seldom reported.

Full description

Repeated Red Light Therapy had been used as an amblyopia therapy for children as well as the myopia control in primary schools. However, ultra low lever of red light therapy with irradiance of 0.37mW and 0.60mW effectiveness and safety for 3~ 6 year-old myopia treatment or slow myopia progression are seldom reported. Here we design this control and random prospective study to find the two types light with different irridance to two ages (3~4 years old and 5~6 years old) respectively. Wether the dose and effectiveness exit or not for 3~6- year- old myopia control.

Enrollment

60 estimated patients

Sex

All

Ages

3 to 6 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 3~6 years old;
  • Myopia Spherical Equivalence Refraction <=-0.50D;
  • Written Informed Consent;

Exclusion criteria

  • Cannot approval with written informed consent;
  • Photophobia or allergy to red light;
  • With other severe conditions the principle investigators refused to enroll this study

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

repeated red light therapy for 3~4 year-old myopia
Experimental group
Description:
0.37mW lighting with wavelength of 650nm for the age of 3\~4 years old(including both 3 and 4 years)myopia.
Treatment:
Device: repeated ultra low lever red light
repeated red light therapy for 5~6 year-old myopia
Experimental group
Description:
0.60mW lighting with wavelength of 650nm for the age of 5\~6 years old(including both 5 and 6 years)myopia.
Treatment:
Device: repeated ultra low lever red light

Trial contacts and locations

1

Loading...

Central trial contact

Wensi Shen, MD,PhD; Jenny Qiu, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems